Filtered by tag: Announcements Remove Filter

23rd Annual Conference on Supportive Care, Hospice, and Palliative Medicine at the MD Anderson Cancer Center

2019    The 23rd Annual Interdisciplinary Conference on Supportive Care, Hospice, and Palliative Medicine will be held October 18-19, 2019 at the MD Anderson Cancer Center in Houston, Texas, USA. Palliative and supportive cancer care are critical to the delivery of optimal care to cancer patients. Many clinicians are unaware of the need for whole-patient care from symptom management to quality of life beyond the treatment of the primary disease. Caring for the cancer patient in the advanced stages of disease is especially challenging and includes medical, psychosocial, ethical, and spiritual dimensions. The conference will help participants learn how to implement new techniques and treatments in clinical practice to improve patient care and outcomes. (Complimentary registration for September 2019 Board Review Attendees!)

Read More

Supportive and Palliative Care Education at the MD Anderson Cancer Center

2019    Updates in Hospice and Palliative Medicine and Intensive Physician Board Review, September 24-26, 2019

Read More

Joint Sessions at ESMO and EONS

2019    Don’t miss these joint sessions at upcoming meetings!

Read More

MASCC at ESMO and EONS

2019    MASCC will have an exhibit at the 2019 Congress of the European Society for Medical Oncology (ESMO) and the European Nursing Society (EONS), both of which take place September 27th to October 1st in Barcelona, Spain. If you are there, please stop by and say hello at Booth S21 in the Society Village!

2019 Update: MASCC/ISOO Clinical Practice Guidelines for the Management of Mucositis Secondary to Cancer Therapy

2019    MASCC’s Mucositis Study Group (MSG) has announced the latest update of the MASCC/ISOO Clinical Practice Guidelines for the Management of Mucositis Secondary to Cancer Therapy. An editorial by MSG Chair Sharon Elad, DMD, MSc, and seven articles have just been published (July 2019) in a Special Section of Supportive Care in Cancer (SCC). This is the first set of papers generated as part of this guideline update and it represents several types of interventions for oral mucositis: anti-inflammatory agents; photobiomodulation; vitamins, minerals, and nutritional supplements; and protocols categorized as basic oral care.

Read More

2019 ISOO Distinguished Service Award — Frederik Spijkervet

2019    Frederik K. (Fred) Spijkervet, DDS, PhD, Head of the Department Oral & Maxillofacial Surgery at the University of Groningen, The Netherlands, is the recipient of ISOO’s 2019 Distinguished Service Award, the Society’s highest honor. The award was given in recognition of many years of meritorious service to ISOO dating back to 1993, when Fred served as the Program Chair for the first international meeting of the Society in Amsterdam. He went on to serve as Vice President of ISOO from 1994 to 1995, as President from 1995 to 1997, and as Scientific Program Chair for the 1997, 1998, and 1999 annual meetings. From 2004 to 2011, Fred chaired the Oral Care Study Group and was an active member of the Mucositis Study Group. From 2008 to 2014, he served as a MASCC Board member and, in 2013, was part of the Scientific Program Committee for the 2013 MASCC/ISOO meeting held in Berlin.

Read More

2019 Study Group Awards

2019    At the 2019 MASCC/ISOO Annual Meeting, seven Study Groups recognized high-quality work by junior investigators in their disciplines. The Fatigue Study Group was the first to honor outstanding young investigators with junior faculty and trainee awards as a means of professional recognition and a way to showcase cutting-edge work by up-and-coming researchers. The awards are based on the quality of abstracts submitted to the Annual Meeting. This year, junior investigator awards were conferred by the Study Groups on Fatigue, Geriatrics, Mucositis, Neurological Complications, Pediatrics, Psychosocial Issues, and Survivorship. In addition, the Fatigue Study Group recognized Debra L. Barton, PhD, FAAN, RN, as Distinguished Scientific Laureate.

Read More

2019 Outstanding Study Group and Study Group Leader Awards

2019    MASCC has initiated two new awards to recognize outstanding work by a MASCC Study Group and an outstanding Study Group Leader. Projects carried out by our Study Groups result in clinical practice guidelines, position papers, publications, and other products that advance supportive care in cancer. Through these new awards, MASCC recognizes excellent work by its Study Groups and the leaders who drive these efforts. The MASCC Mucositis Study Group was named the 2019 Outstanding Study Group, and Mucositis SG Chair Sharon Elad, DMD, MSc, was named the 2019 Outstanding Study Group Leader.

Read More

2019 Travel Scholarship Awards

2019     Cynthia N. Rittenberg Travel Scholarship Award 2019 - Radhika R. Pai, MSc (India)
From among the Travel Scholarship applicants, the nurse applicant with the highest-ranking abstract is awarded the Cynthia N. Rittenberg Travel Scholarship. This year, the award went to Radhika R. Pai, MSc (India) for her abstract titled “Evaluation of an Oral Care Protocol for Chemotherapy- and Radiation Therapy-Induced Oral Complications in Head and Neck Cancer Patients.” Radhika is an Assistant Professor in the Department of Fundamentals of Nursing Manipal College of Nursing in Udupi, India. A member of MASCC and ISOO, Radhika belongs to MASCC Study Groups on Oral Care, Hemostasis, and Palliative Care.

Read More

2019 Young Investigator Awards

2019    Derek K. Smith, DDS, PhD, is the recipient of MASCC’s 2019 Outstanding Young Investigator Award for his research on the efficacy of gabapentin in reducing neuropsychiatric symptoms in patients receiving primary or adjuvant chemoradiation for head and neck cancer. Derek is Research Assistant Professor of Biostatistics and Oral Maxillofacial Surgery and Assistant Director of Supportive Oncology at Vanderbilt University Medical Center in Nashville, Tennessee, USA. He is particularly interested in the impact that cancer therapies can have on oral health, and how the healthcare system can address the unique challenges of maintaining good oral health in cancer patients. He is a member of MASCC and ISOO and of the Oral Care Study Group.

Read More

2019 Steven M. Grunberg Memorial Award – Jane Ussher

2019    Jane Ussher, PhD, of the University of Western Sydney, Australia, is the winner of MASCC’s 2019 Steven M. Grunberg Memorial Award for her research titled “Sexual Issues in Partners of Cancer Patients.” The Steven M. Grunberg Memorial Award is reserved for the author of the highest-ranking abstract submitted to the Annual Meeting and rewards demonstrated excellence in supportive care in cancer. At this year’s Annual Meeting, Jane presented her study of sexual embodiment and subjectivity after cancer across a range of cancer types and stages in partners of people with cancer, across both heterosexual and LGBT relationships.

Read More

2019 MASCC Distinguished Service Award - Rachel Gibson

2019    Rachel Gibson, PhD, is the recipient of MASCC’s 2019 Distinguished Service Award. The DSA, MASCC’s highest honor, is made in recognition of meritorious achievement and outstanding contributions to the society. Candidates are nominated by their peers in recognition of exemplary leadership and accomplishments in support of MASCC’s mission and goals. Rachel has just been appointed inaugural Professor and Director, Allied Health in the Faculty of Health and Medical Sciences at the University of Adelaide, a position that will commence in July 2019. She is also Co-Head of the Cancer Treatment Toxicities Group at the Adelaide Medical School and previously served as Professor and Academic Dean in the Division of Health Sciences, University of South Australia.

Read More

2019 Annual Meeting Highlights & Reminders

2019 The 2019 MASCC/ISOO Annual Meeting offers an exciting variety of sessions and speakers.

Read More

NICSO-A New MASCC Affiliate

2019    MASCC signed an affiliation agreement with the Network Italiano Cure di Supporto in Oncologia (NICSO), the Italian network of supportive care in oncology. With MASCC affiliation, members of NICSO become full members of MASCC with all membership benefits.

NICSO was formed in 2014 as an open multidisciplinary association for all those who work with patients with cancer. Its mission is to stimulate and facilitate training and scientific research on cancer support therapies in order to offer patients a better quality of life. It aims to improve prevention and treatment of symptoms, co-morbidity, and side effects of anticancer therapies from the time of diagnosis through treatment, post-treatment, and rehabilitation.

Read More

AFSOS- A New MASCC Affiliate

2019     MASCC signed an affiliation agreement with the Association Francophone des Soins Oncologiques de Support (AFSOS), the French-speaking association for supportive care in in oncology. With MASCC affiliation, members of AFSOS become full members of MASCC with all membership benefits.

Read More

MASCC/ESMO Antiemetic Guidelines Update

2016    The MASCC/ESMO Antiemetic Guidelines have been updated as of March, 2016. The guidelines are based on the Copenhagen Consensus Conference on Antiemetic Therapy, June 2015, and have been endorsed by both MASCC and ESMO. This set of evidence-based guidelines represents several important changes and first-time inclusions. This is the first time that recommendations about management of nausea and vomiting in advanced cancer have been included — as opposed to only nausea and vomiting induced by chemotherapy or radiotherapy — and in this respect, the new MASCC/ESMO guidelines differ from those of NCCN and ASCO. The new guidelines contain recommendations for two new NK1 receptor antagonists, rolapitant and netupitant, the latter given in combination with palonosetron (NEPA), and also discuss the use of olanzapine. The combination of an anthracycline with cyclophosphamide, previously considered of medium emetogenic risk (30-90% risk of vomiting) is now considered a high-risk combination (>90% risk of vomiting). However, this remains a special case, since recommendations for the delayed phase differ from those of other chemotherapies of highly emetogenic risk. In addition, carboplatin is now considered a special case with an indication for triple preventative therapy in the acute phase.

Read More

MASCC/ISOO Study Group Chairs Lead Study on Oral Complications of Radiotherapy

2012    Carolinas HealthCare System (CHS) Receives $8 Million NIH Grant to Conduct First-Ever Study of its Kind. CHS’s Carolinas Medical Center has been awarded an $8 million grant from the National Institute of Dental and Craniofacial Research (NIDCR) to study dental and oral medicine outcomes of patients who have received high-dose radiation to the head and neck region. This is the largest research grant ever awarded to CHS. As the awardee organization, CHS will administer the grant, which will be shared across the several sites involved in the study. Each year 40,000 Americans develop head and neck cancer, and many have to receive high-dose radiation therapy, often in combination with surgery and/or chemotherapy. An unavoidable side effect of radiation therapy is damage to the oral and maxillofacial tissues, some of which persist for the lifetime of the patient.

Read More